An early stage developmental biopharmaceutical company…with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will …
BEVERLY, MA--(Marketwired - Sep 2, 2014) - Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage …
stock exchanges, Investment & Money Management Ideas. News Today: BEVERLY, MA, Jun 03, 2010--Cellceutix …
On Friday the stock traded over 37 million shares closing at $0.1585 up 30% from its previous close. Cellceutix Corp …
CTIX is still a “sleeper” in the stock market world, but certainly portrays many of the qualities of a biotech that could …
CTIX.OB closed Wednesday's trading at $1.59, down 2.45%. Cynapsus Therapeutics Inc. (CYNA) has a number of milestones to achieve in the coming months, which can have a significant impact on its stock price. Top-line data from …
Cellceutix Corp. (OTCQB: CTIX) enjoyed strong stock volume Apr. 25, with 180,001 shares changing hands. The solid showing comes less than two weeks after the Beverly, Mass.-based pharmaceutical company reported favorable results …
Now that ONVO has joined the New York Stock Exchange, the company has been cleared for a huge takeoff. But there's one more company that investors should consider given its goals of uplisting to a major exchange. The company is …
CTIX). ABBY Energy (OTC: ABBY) came on to the volume watch list today ahead of tomorrow's trading session. We …
Cellceutix Corporation, (OTC: CTIX) is pleased to provide additional information in ... including the amount and timing of the sale of shares of common stock to Aspire Capital; the fact that Cellceutix's compounds may not successfully complete …